MEDNAX INC's gross profit margin for the first quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased.
During the same period, stockholders' equity ("net worth") has increased by 16.43% from the same quarter last year.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY16||Q1 FY15|
|Net Sales ($mil)||752.62||639.4|
|Net Income ($mil)||67.9||68.71|
|Balance Sheet||Q1 FY16||Q1 FY15|
|Cash & Equiv. ($mil)||64.28||56.99|
|Total Assets ($mil)||4636.29||3646.31|
|Total Debt ($mil)||1442.7||897.16|
|Profitability||Q1 FY16||Q1 FY15|
|Gross Profit Margin||31.06||30.71|
|Return on Assets||7.23||8.83|
|Return on Equity||13.63||15.25|
|Debt||Q1 FY16||Q1 FY15|
|Share Data||Q1 FY16||Q1 FY15|
|Shares outstanding (mil)||93.74||93.45|
|Div / share||0.0||0.0|
|Book value / share||26.25||22.61|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||876650.0||860893.0|
BUY. This stock's P/E ratio indicates a discount compared to an average of 23.33 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 23.99. To use another comparison, its price-to-book ratio of 2.70 indicates valuation on par with the S&P 500 average of 2.74 and a discount versus the industry average of 3.38. The price-to-sales ratio is above the S&P 500 average and well above the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, MEDNAX INC proves to trade at a discount to investment alternatives within the industry.
|MD 19.71||Peers 23.33||MD NA||Peers 14.63|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
MD is trading at a discount to its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|MD 15.38||Peers 15.76||MD 1.07||Peers 0.93|
Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.
MD is trading at a valuation on par with its peers.
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
MD trades at a premium to its peers.
|MD 2.70||Peers 3.38||MD 10.12||Peers 62.97|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
MD is trading at a discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, MD is expected to significantly trail its peers on the basis of its earnings growth rate.
|MD 2.29||Peers 0.80||MD 15.17||Peers 14.39|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
MD is trading at a significant premium to its industry.
Average. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.
MD is keeping pace with its peers on the basis of sales growth.
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.